Guest Edited by Professor Steve Soper, University of North Carolina, USA and Dr Avraham Rasooly, National Cancer Institute, National Institutes of Health, USA, this collection is devoted to new technologies focused on the management of cancer-related diseases and covers a broad spectrum of new innovations including optical sensors (SERS, fluorescence, plasmon resonance, etc.), drug delivery vehicles, affinity agents, imaging contrast agents, microfluidics/nanofluidics and cell-based assays to name a few.
Cancer remains a devastating disease with 580,350 deaths and 1.66 million new cases reported in the US alone in 2013. With 7.5 million deaths worldwide, cancer is the number 1 killer globally. Although 5-year survival rates have risen from 50% in 1975-77 to 68% in 2003-2008, major challenges remain toward further improving survival rates. The keys to realizing increased 5-year survival rates depend on significant improvements in early detection strategies as well as personalized treatment selection and effectively monitoring for disease recurrence. All of these focus areas can be enhanced through the development of new technological tools. Thus, this themed issue serves as a timely dissemination of new technologies that hold promise for the management of a variety of cancer-related diseases.